Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pathologic Complete Response × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 7 Gastrointestinal 5 Thoracic 1 Plasma cell 1 Other hematologic neoplasm 1 Dermatologic 1

Conditions

Melanoma 265 Carcinoma, Basal Cell 48 Skin Neoplasms 44 Lymphoma, T-Cell, Cutaneous 33 Breast Neoplasms 27 Neoplasms 26 Uveal Melanoma 24 Carcinoma, Non-Small-Cell Lung 23 Lung Neoplasms 22 Neoplasm Metastasis 21 Keratosis, Actinic 21 Carcinoma, Squamous Cell 17 Carcinoma, Renal Cell 17 Mycosis Fungoides 15 Lymphoma, Large B-Cell, Diffuse 15 Lymphoma 15 Hodgkin Disease 15 Urinary Bladder Neoplasms 14 Lymphoma, Non-Hodgkin 14 Lymphoma, Follicular 14 Leukemia, Lymphocytic, Chronic, B-Cell 14 Sezary Syndrome 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Pancreatic Neoplasms 13 Lymphoma, Mantle-Cell 13 Lymphoma, B-Cell, Marginal Zone 13 Burkitt Lymphoma 13 Ovarian Neoplasms 12 Lymphoma, Large-Cell, Immunoblastic 12 Colorectal Neoplasms 12

Interventions

Cell-Free Nucleic Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02907827 2020-12-17

DW-MRi

Universitair Ziekenhuis Brussel

Phase NA Unknown

Pathologic Complete Response, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡